Wernau Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.34M Sell
116,951
-2,774
-2% -$73.8K 1.54% 10
2026
Q2
$2.88M Buy
119,725
+5,694
+5% +$149K 1.5% 12
2026
Q1
$3.2M Buy
114,031
+149
+0.1% +$3.97K 2.23% 9
2025
Q4
$2.84M Sell
113,882
-8,259
-7% -$208K 1.53% 11
2025
Q3
$3.11M Sell
122,141
-2,183
-2% -$53.9K 2.12% 9
2025
Q2
$3.01M Sell
124,324
-41,320
-25% -$964K 2.09% 9
2025
Q1
$4.2M Buy
165,644
+12,096
+8% +$317K 3.28% 8
2024
Q4
$4.07M Buy
+153,548
New +$4.16M 3.04% 9

Other funds holding PFE

Wernau Asset Management's PFE Position: Q3 2026 in Review

Wernau Asset Management reduced its Pfizer (PFE) stake by 2.3% in Q3 2026, selling an estimated $73.8K and leaving 116,951 shares worth $3.34M. The position accounts for 1.54% of the portfolio, ranked #10.

Wernau Asset Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.2M in Q1 2025. 2,016 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Wernau Asset Management held 116,951 shares of Pfizer worth $3.34M as of Q3 2026.
  • Wernau Asset Management sold 2,774 Pfizer shares in Q3 2026, an estimated $73.8K.
  • Pfizer made up 1.54% of Wernau Asset Management's portfolio in Q3 2026, its #10 holding.
  • Wernau Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • Wernau Asset Management's Pfizer position peaked at $4.2M in Q1 2025.
  • 2,016 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Wernau Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.